News

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...
Shares in Novo Nordisk fell as much as six per cent on Friday to their lowest since August 2021, extending recent losses to ...
Novo Nordisk on Tuesday slashed its forecast for 2025 sales growth due to competition from compounded, or copycat, versions ...
The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...
Eli Lilly stock is set to report Q2 2025 earnings on August 7, with consensus expecting $14.4 billion in revenue and $5.56 EPS, up 30-42% YoY. Read the full earnings preview here.
WASHINGTON: The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the ...